230 related articles for article (PubMed ID: 22316195)
1. A review of current indications, adverse effects, and administration recommendations for intravenous immunoglobulin.
Spurlock NK; Prittie JE
J Vet Emerg Crit Care (San Antonio); 2011 Oct; 21(5):471-83. PubMed ID: 22316195
[TBL] [Abstract][Full Text] [Related]
2. Human intravenous immunoglobulin therapy.
Scott-Moncrieff JC; Reagan WJ
Semin Vet Med Surg Small Anim; 1997 Aug; 12(3):178-85. PubMed ID: 9283243
[TBL] [Abstract][Full Text] [Related]
3. Use of human immunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated hemolytic anemia.
Whelan MF; O'Toole TE; Chan DL; Rozanski EA; DeLaforcade AM; Crawford SL; Cotter SM
J Vet Emerg Crit Care (San Antonio); 2009 Apr; 19(2):158-64. PubMed ID: 19691566
[TBL] [Abstract][Full Text] [Related]
4. Intravenous administration of human immune globulin in dogs with immune-mediated hemolytic anemia.
Scott-Moncrieff JC; Reagan WJ; Snyder PW; Glickman LT
J Am Vet Med Assoc; 1997 Jun; 210(11):1623-7. PubMed ID: 9170090
[TBL] [Abstract][Full Text] [Related]
5. Human intravenous immunoglobulin use for hematological immune-mediated disease in dogs.
Kane BK; Greer RM
J Am Vet Med Assoc; 2023 Jul; 261(7):1004-1010. PubMed ID: 37072115
[TBL] [Abstract][Full Text] [Related]
6. Use of Human Intravenous Immunoglobulin in Veterinary Clinical Practice.
Spurlock N; Prittie J
Vet Clin North Am Small Anim Pract; 2020 Nov; 50(6):1371-1383. PubMed ID: 32896436
[TBL] [Abstract][Full Text] [Related]
7. [Use of human intravenous immunoglobulin in dogs with primary immune mediated hemolytic anemia].
Gerber B; Steger A; Hässig M; Glaus TM
Schweiz Arch Tierheilkd; 2002 Apr; 144(4):180-5. PubMed ID: 12038216
[TBL] [Abstract][Full Text] [Related]
8. Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature.
Schiavotto C; Ruggeri M; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):35-40. PubMed ID: 8039756
[TBL] [Abstract][Full Text] [Related]
9. A prospective, randomized, double-blinded, placebo-controlled study of human intravenous immunoglobulin for the acute management of presumptive primary immune-mediated thrombocytopenia in dogs.
Bianco D; Armstrong PJ; Washabau RJ
J Vet Intern Med; 2009; 23(5):1071-8. PubMed ID: 19674280
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of the combination of glucocorticoids, mycophenolate-mofetil and human immunoglobulin for the therapy of immune mediated haemolytic anaemia in dogs].
Oggier D; Tomsa K; Mevissen M; Glaus T
Schweiz Arch Tierheilkd; 2018 Mar; 160(3):171-178. PubMed ID: 29509140
[TBL] [Abstract][Full Text] [Related]
11. Increasing patient safety in veterinary transfusion medicine: an overview of pretransfusion testing.
Tocci LJ; Ewing PJ
J Vet Emerg Crit Care (San Antonio); 2009 Feb; 19(1):66-73. PubMed ID: 19691586
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized clinical trial of vincristine versus human intravenous immunoglobulin for acute adjunctive management of presumptive primary immune-mediated thrombocytopenia in dogs.
Balog K; Huang AA; Sum SO; Moore GE; Thompson C; Scott-Moncrieff JC
J Vet Intern Med; 2013; 27(3):536-41. PubMed ID: 23527952
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulins in the therapy of autoimmune and systemic inflammatory disorders.
Mobini N; Sarela A; Ahmed AR
Ann Allergy Asthma Immunol; 1995 Feb; 74(2):119-28; quiz 128-33. PubMed ID: 7697470
[TBL] [Abstract][Full Text] [Related]
14. Guidelines on the use of intravenous immune globulin for hematologic conditions.
Anderson D; Ali K; Blanchette V; Brouwers M; Couban S; Radmoor P; Huebsch L; Hume H; McLeod A; Meyer R; Moltzan C; Nahirniak S; Nantel S; Pineo G; Rock G
Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S9-56. PubMed ID: 17397769
[TBL] [Abstract][Full Text] [Related]
15. Treatment of severe immune-mediated thrombocytopenia with human IV immunoglobulin in 5 dogs.
Bianco D; Armstrong PJ; Washabau RJ
J Vet Intern Med; 2007; 21(4):694-9. PubMed ID: 17708388
[TBL] [Abstract][Full Text] [Related]
16. Transfusion medicine in small animal practice.
Tocci LJ
Vet Clin North Am Small Anim Pract; 2010 May; 40(3):485-94. PubMed ID: 20471531
[TBL] [Abstract][Full Text] [Related]
17. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
Dalakas MC
Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic options for immune-mediated thrombocytopenia.
Nakamura RK; Tompkins E; Bianco D
J Vet Emerg Crit Care (San Antonio); 2012 Feb; 22(1):59-72. PubMed ID: 22316417
[TBL] [Abstract][Full Text] [Related]
19. The association of blood lactate concentration with outcome in dogs with idiopathic immune-mediated hemolytic anemia: 173 cases (2003-2006).
Holahan ML; Brown AJ; Drobatz KJ
J Vet Emerg Crit Care (San Antonio); 2010 Aug; 20(4):413-20. PubMed ID: 20731807
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin: properties, mode of action and practical use in dermatology.
Prins C; Gelfand EW; French LE
Acta Derm Venereol; 2007; 87(3):206-18. PubMed ID: 17533485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
